The NCPE are currently advertising for the position of Program Manager. Further details are available here
This webinar is open to members of Patient Organisations who would like to find out more about the NCPE Patient Organisation Submission Process. Joan O’Callaghan and Dr. Laura Mc Cullagh will cover topics including: Why make a Patient Organisation submission? Overview of the Patient Organisation Submission Process Interpreting NCPE […]
At their meeting at the end of January 2024 the Heads of HTA Agencies issued a statement highlighting areas of particular interest for HTA in the revised Pharmaceutical Legislation for the European Union. See full statement here
Version 1.8 of this template was published on 08 May 2023 and replaces version 1.7. The new version is available here For those companies who have already started to prepare a Budget Impact Model, the previous version of the template (Version 1.7) will be acceptable until 01 August 2023.
Version 3.0 of the Full HTA Submission Template is available here. This template, to be completed by Applicants, outlines the content and format of the written submission to the NCPE as part of a full HTA. For those companies who have already started to prepare a full HTA submission, the […]
Dr. Roisin Adams, NCPE elected as Chair of the Health Technology Assessment Coordination Group.On 28 November 2022, the HTA Coordination Group (HTACG) elected its Chair, Dr. Roisin Adams, National Centre for Pharmacoeconomics, Ireland and co-chairs, Niklas Hedberg Dental and Pharmaceuticals Benefits Agency, Sweden and Marco Marchetti, National Agency for Regional […]
Notice to Applicants: Please refer to updated versions of the RR Submission Template v2.2, Applicant Template v2.1, and the Submission Checklist v1.4 when making submissions. These are available from the Submission Templates section of the website.
Version 2.1 of the Rapid Review Submission templates includes a requirement to submit the NCPE Budget Impact Model Template for all Rapid Review submissions. Version 2.1 of this template was published on 07 April 2022 and replaces version 2.0. Submissions using the old template (version 2.0) will be accepted until 12 May 2022.
Notice for Applicants: Please refer to updated versions of the Guidelines for Inclusion of Drug Costs v3.1, Applicant submission template v2. and the Budget Impact Model Template v1.5 when making submissions.